Back to Stakeholders

Assistance Publique – Hôpitaux de Paris (AP-HP) is France's largest public hospital system, comprising 39 hospitals including Pitié-Salpêtrière and Sainte-Anne, and serving as Europe's leading academic medical center complex with extensive clinical research infrastructure. AP-HP institutions actively contribute to psychedelic medicine research, including participation in COMPASS Pathways' Phase 3 psilocybin trials for treatment-resistant depression and ketamine studies through the Paris Brain Institute.

Academic Research

0 papers

Published Papers

0

Trial Involvement

2

Distinct Focus Topics

0

Latest Publication

Unknown

Clinical Care Delivery Snapshot

Health Systems & Hospitals

Provider Model

Health System / Hospital Program

Organization Status

Unknown

Psychedelic Services

Unknown

Service Coverage

Global

Service Profile

Care Settings

Hospital Outpatient

Payer Models

Unknown

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Backfilled profile for existing L2 clinical care delivery stakeholder.

Quick Facts

Type
Other
HQ
France
Website
Visit

Sponsored Trials

2